Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials

por Perez, Raymond, Archdeacon, Patrick, Roach, Nancy, Goodwin, Robert, Jarow, Jonathan, Stuccio, Nina, Forrest, Annemarie
Publicado 2017

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

por Jarow, Jonathan, Maher, V. Ellen, Tang, Shenghui, Ibrahim, Amna, Kim, Geoffrey, Sridhara, Rajeshwari, Pazdur, Richard
Publicado 2015

Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

por Lerner, Seth P., Bajorin, Dean F., Dinney, Colin P., Efstathiou, Jason A., Groshen, Susan, Hahn, Noah M., Hansel, Donna, Kwiatkowski, David, O’Donnell, Michael, Rosenberg, Jonathan, Svatek, Robert, Abrams, Jeffrey S., Al-Ahmadie, Hikmat, Apolo, Andrea B., Bellmunt, Joaquim, Callahan, Margaret, Cha, Eugene K., Drake, Charles, Jarow, Jonathan, Kamat, Ashish, Kim, William, Knowles, Margaret, Mann, Bhupinder, Marchionni, Luigi, McConkey, David, McShane, Lisa, Ramirez, Nilsa, Sharabi, Andrew, Sharpe, Arlene H., Solit, David, Tangen, Catherine M., Amiri, Abdul Tawab, Van Allen, Eliezer, West, Pamela J., Witjes, J. A., Quale, Diane Zipursky
Publicado 2016